ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma.

Wendi YangKehong ChenQian YuRongxin LiaoHengqiu HeYuan PengZhen Zhou YangXiaoyue Zhang

Published in: Cancer medicine (2023)

The findings of our study suggested that ADAR1 may be useful in predicting prognosis and LNM in LUAD, and may serve as a promising immune-related molecular target for LUAD patients.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
single molecule
patient reported